STAT3 and prostate neoplasm: Antisense oligonucleotides provide another distinctly different approach to inhibit cellular STAT3, inhibiting immunosuppressive MDSCs and enhancing anti-tumor immunity, which could effectively eradicate prostate tumors in a mouse model [257].